Literature DB >> 12102744

Tuning tumor-specific T-cell activation: a matter of costimulation?

Hinrich Abken1, Andreas Hombach, Claudia Heuser, Kai Kronfeld, Barbara Seliger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12102744     DOI： 10.1016/s1471-4906(02)02180-4

Source DB:  PubMed          Journal:  Trends Immunol        ISSN： 1471-4906            Impact factor:   16.687


× No keyword cloud information.
  19 in total

1.  CD28-mediated costimulation impacts on the differentiation of DC vaccination-induced T cell responses.

Authors:  H Voigt; D Schrama; A O Eggert; C S Vetter; K Müller-Blech; H M Reichardt; M H Andersen; J C Becker; F Lühder
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

Review 2.  Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumors.

Authors:  Melissa G Lechner; Sarah M Russell; Rikki S Bass; Alan L Epstein
Journal:  Immunotherapy       Date:  2011-11       Impact factor: 4.196

Review 3.  Colon cancer and the immune system: the role of tumor invading T cells.

Authors:  Maximilian Waldner; Carl-C Schimanski; Markus-F Neurath
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

4.  Molecular insights into γδ T cell costimulation by an anti-JAML antibody.

Authors:  Petra Verdino; Deborah A Witherden; M Sharon Ferguson; Adam L Corper; André Schiefner; Wendy L Havran; Ian A Wilson
Journal:  Structure       Date:  2011-01-12       Impact factor: 5.006

5.  Immunoglobulin G from breast cancer patients in stage I stimulates muscarinic acetylcholine receptors in MCF7 cells and induces proliferation. Participation of nitric oxide synthase-derived nitric oxide.

Authors:  María Pía Negroni; Gabriel L Fiszman; María E Azar; Carlos Cresta Morgado; Alejandro J Español; Laura T Pelegrina; Eulalia de la Torre; María Elena Sales
Journal:  J Clin Immunol       Date:  2010-02-16       Impact factor: 8.317

6.  Enhanced sensitivity to IL-2 signaling regulates the clinical responsiveness of IL-12-primed CD8(+) T cells in a melanoma model.

Authors:  Dominique N Lisiero; Horacio Soto; Linda M Liau; Robert M Prins
Journal:  J Immunol       Date:  2011-03-23       Impact factor: 5.422

7.  Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas.

Authors:  Anna Kruschinski; Andreas Moosmann; Isabel Poschke; Håkan Norell; Markus Chmielewski; Barbara Seliger; Rolf Kiessling; Thomas Blankenstein; Hinrich Abken; Jehad Charo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-05       Impact factor: 11.205

Review 8.  B7-H1 pathway and its role in the evasion of tumor immunity.

Authors:  Haidong Dong; Lieping Chen
Journal:  J Mol Med (Berl)       Date:  2003-04-30       Impact factor: 4.599

9.  Immunoglobulin g from breast cancer patients regulates MCF-7 cells migration and MMP-9 activity by stimulating muscarinic acetylcholine receptors.

Authors:  Laura T Pelegrina; María Gabriela Lombardi; Gabriel L Fiszman; María E Azar; Carlos Cresta Morgado; María E Sales
Journal:  J Clin Immunol       Date:  2012-09-25       Impact factor: 8.317

10.  Induction of an antitumour adaptive immune response elicited by tumour cells expressing de novo B7-1 mainly depends on the anatomical site of their delivery: the dose applied regulates the expansion of the response.

Authors:  Silvia Sartoris; Maria G Testi; Elisabetta Stefani; Roberto Chignola; Chiara Guerriero; Andrea Matucci; Tiziana Cestari; Aldo Scarpa; Anna P Riviera; Giovanna Zanoni; Giuseppe Tridente; Giancarlo Andrighetto
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.